Literature DB >> 24820973

Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS.

Liusheng Huang1, Patricia Lizak2, Christopher C Dvorak3, Francesca Aweeka2, Janel Long-Boyle2.   

Abstract

A method for quantification of fludarabine (FDB) and clofarabine (CFB) in human plasma was developed with an API5000 LC-MS/MS system. FDB and CFB were extracted from EDTA plasma samples by protein precipitation with trichloroacetic acid. Briefly, 50 μL plasma sample was mixed with 25 μL internal standard (50 ng/mL aqueous 2-Cl-adensosine) and 25 μL 20% trichloroacetic acid, centrifuged at 25,000 × g (20,000 rpm) for 3 min, and then transfered to an autosampler vial. The extracted sample was injected onto an Eclipse extend C18 column (2.1 mm×150 mm, 5 μm) and eluted with 1mM NH4OH (pH 9.6) - acetonitrile in a gradient mode. Electrospray ionization in positive mode (ESI(+)) and multiple reaction monitoring (MRM) were used, and ion pairs 286/134 for FDB, 304/170 for CFB and 302/134 for the internal standard were selected for quantification. The retention times were typically 3.72 min for FDB, 4.34 min for the internal standard, 4.79 min for CFB. Total run time was 10 min per sample. Calibration range was 0.5-80 ng/mL for CFB and 2-800 ng/mL for FDB. The method was applied to a clinical pharmacokinetic study in pediatric patients.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clofarabine; Fludarabine; LC–MS/MS; Plasma

Mesh:

Substances:

Year:  2014        PMID: 24820973      PMCID: PMC4110960          DOI: 10.1016/j.jchromb.2014.04.045

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  17 in total

1.  Determination of fludarabine in a pharmaceutical formulation by LC.

Authors:  R Ficarra; M L Calabrò; S Tommasini; A Villari; S Melardi; S Coppolino; M Semreen; P Ficarra
Journal:  J Pharm Biomed Anal       Date:  1999-12       Impact factor: 3.935

2.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS.

Authors:  B K Matuszewski; M L Constanzer; C M Chavez-Eng
Journal:  Anal Chem       Date:  2003-07-01       Impact factor: 6.986

3.  Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.

Authors:  B Horn; L-A Baxter-Lowe; L Englert; A McMillan; M Quinn; K Desantes; M Cowan
Journal:  Bone Marrow Transplant       Date:  2006-02       Impact factor: 5.483

4.  Comparison of fast liquid chromatography/tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma.

Authors:  Yunsheng Hsieh; Christine J G Duncan; Suining Lee; Ming Liu
Journal:  J Pharm Biomed Anal       Date:  2007-02-13       Impact factor: 3.935

Review 5.  Discovery and development of clofarabine: a nucleoside analogue for treating cancer.

Authors:  Peter L Bonate; Larry Arthaud; William R Cantrell; Katherine Stephenson; John A Secrist; Steve Weitman
Journal:  Nat Rev Drug Discov       Date:  2006-10       Impact factor: 84.694

6.  Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution.

Authors:  Jason Law; Morton J Cowan; Christopher C Dvorak; Lisa Musick; Janel R Long-Boyle; Lee Ann Baxter-Lowe; Biljana Horn
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-15       Impact factor: 5.742

7.  Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.

Authors:  L W Dow; D E Bell; L Poulakos; A Fridland
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

8.  Simultaneous quantification of fludarabine and cyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

Authors:  L H H Silvertand; F Vazvaei; P Weigl; H Rosing; M J X Hillebrand; M J van Maanen; J H Beijnen
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

9.  Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.

Authors:  R W Brockman; Y C Cheng; F M Schabel; J A Montgomery
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

10.  Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation.

Authors:  Janel Long-Boyle; Jiayin Huang; Nancy Rydholm; Angela Smith; Paul Orchard; Jakub Tolar; Pamala Jacobson
Journal:  J Clin Pharmacol       Date:  2010-06-04       Impact factor: 2.860

View more
  4 in total

1.  Determination of melphalan in human plasma by UPLC-UV method.

Authors:  Liusheng Huang; Vincent Cheah; Danna Chan; Florence Marzan; Christopher C Dvorak; Francesca T Aweeka; Janel Long-Boyle
Journal:  Cancer Chemother Pharmacol       Date:  2019-02-13       Impact factor: 3.333

2.  Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients.

Authors:  Vijay Ivaturi; Christopher C Dvorak; Danna Chan; Tao Liu; Morton J Cowan; Justin Wahlstrom; Melisa Stricherz; Cathryn Jennissen; Paul J Orchard; Jakub Tolar; Sung-Yun Pai; Liusheng Huang; Francesca Aweeka; Janel Long-Boyle
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-03       Impact factor: 5.742

3.  Determination of unbound piperaquine in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry.

Authors:  Liusheng Huang; Vong Sok; Usman Aslam-Mir; Florence Marzan; Meghan Whalen; Philip J Rosenthal; Francesca Aweeka
Journal:  J Chromatogr Open       Date:  2022-03-14

4.  Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid.

Authors:  Liusheng Huang; Janus Anders Juul Haagensen; Davide Verotta; Vincent Cheah; Alfred M Spormann; Francesca Aweeka; Katherine Yang
Journal:  J Anal Methods Chem       Date:  2018-04-26       Impact factor: 2.193

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.